American scientists are reportedly working on a “space vaccine” that could also improve the lives of aging populations.
Researchers at the University of Central Florida (UCF) are reportedly working with biotechnology company Vaxxinity to develop a vaccine to prevent and relieve muscle and bone weakness, the Miami Herald reported Saturday morning.
This collaboration, supported by government funding, aims to treat atrophy and bone and muscle loss, a common health problem among astronauts undertaking extended weightless journeys, but also among the elderly.
The number of people ages 85 and older in the United States is expected to triple by 2060. In this context, research that can lead to longer and healthier lives is becoming increasingly important for American researchers.
“We look forward to collaborating with Vaxxinity on this research and leveraging their unique technology to benefit our planet’s aging population and future space travelers,” said Deborah, vice president of business affairs at Vaxxinity, in an announcement. Health and Dean of the UCF School of Medicine, Deborah Deutsch.
If all goes well, human clinical trials for the vaccines could begin as early as 2025, Lou Reese, co-founder and chief executive of Vaxxinity, told the Miami Herald.